Biochemical markers have a central position in the diagnosis and management of patients
in clinical medicine, and also in clinical research and drug development, also for brain …

BACKGROUND: Numerous studies show that the cerebrospinal fluid biomarkers total tau (T-tau),
tau phosphorylated at threonine 181 (P-tau 181P ), and amyloid-β (1-42) (Aβ 1–42 ) …

Early diagnosis of neurodegenerative disorders such as Alzheimer’s (AD) or Parkinson’s
disease (PD) is needed to slow down or halt the disease at the earliest stage. Cerebrospinal …

Background Cerebrospinal fluid (CSF) biomarkers β-amyloid 1-42 (Aβ 1-42 ), also expressed
as Aβ 1-42 :Aβ 1-40 ratio, T-tau, and P-tau 181P , have proven diagnostic accuracy for mild …

α-Synuclein is the major protein associated with Lewy body dementia, Parkinson’s disease
and multiple system atrophy. Since α-synuclein is present in the brain in physiological …

Background The evolution of the variant Creutzfeldt-Jakob disease (vCJD) epidemic is
hazardous to predict due to uncertainty in ascertaining the prevalence of infection and because …

Tau proteins and amyloid-ß (Aß) peptides are the current recognized cerebrospinal fluid (CSF)
biomarkers used as an aid in the diagnosis of Alzheimer’s disease (AD). However, there …

The emergence of variant Creutzfeldt Jakob Disease (vCJD) is considered a likely consequence
of human dietary exposure to Bovine Spongiform Encephalopathy (BSE) agent. More …

The E200K mutation is the most frequent prion protein gene (PRNP) mutation detected
worldwide that is associated with Creutzfeldt-Jakob disease (CJD) and thought to have …

Sporadic Creutzfeldt-Jakob disease (sCJD) cases are currently subclassified according to
the methionine/valine polymorphism at codon 129 of the PRNP gene and the proteinase K (PK…